iLine Microsystems S.L. of San Sebastián (Donostia) at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

iLine Microsystems S.L.

Paseo Mikeletegi, 69, 20009 San Sebastián (Donostia)
Telephone +34 943 005651
Fax +34 943 008737

Hall map

MEDICA 2019 hall map (Hall 3): stand C71

Fairground map

MEDICA 2019 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.03  Haematology / histology / cytology testing
  • 03.03.01  Haematology analyzers

Haematology analyzers

Our products

Product category: Haematology analyzers


The next generation Point of Care and self-testing system for OAT monitoring
The microINR system is intended for the monitoring of vitamin K antagonist Oral Anticoagulation Therapy (OAT). The microINR Chip and Meter have been developed to fulfill the needs of all the existing OAT monitoring models, and have received the CE mark for patient self-testing and for use by healthcare providers making it suitable for both intended uses.

The microINR system tackles these demands through its compact easy-to- use design, automatic calibration, low-volume sample requirement and multilevel quality control.

The microINR system employs patent granted technology and provides accurate and reproducible results as proven in extensive performance evaluations..

More Less

About us

Company details

The next generation of Point of Care
As a result of years of biomedical and biotechnological research on Point of Care diagnostic solutions, iLine Microsystems was founded in 2007 with the aim to meet the needs of current and future healthcare models, improving the efficiency of healthcare professionals and patient’s quality of life.

Our company designs and manufactures innovative Point of Care medical devices on the hemostasis field exploiting the advantages of both microfluidics and Lab-on-a-Chip technological concepts under the company´s proprietary core technology.

The performance and usability of our products, manufactured following the highest guidelines and quality standards and supported by several scientific studies, consolidate them as the next generation of Point of Care systems in the field of hemostasis.

More Less